← Eichor
Condition: Trop2 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Trop2

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer
Phase 2 · 2 location(s) · Fudan University · NCT07471776A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors
Phase 1 · 1 location(s) · Akeso · NCT06929663PET/CT for Trop2 ADC Response Evaluation NSCLC
Phase N/A · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT07151898Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07589530Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
Phase 2 · 1 location(s) · Brown University · NCT06974604A Phase II Study of Sacituzumab Tirumotecan in Combination With Furmonertinib in Patients With Non-squamous Non-Small Ce
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07548060A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
Phase 1/Phase 2 · 17 location(s) · Biohaven Therapeutics Ltd. · NCT0638480799mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer
NA · 1 location(s) · Peking Union Medical College Hospital · NCT06104085Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer
Phase N/A · 1 location(s) · Yunnan Cancer Hospital · NCT06972771Trop2-targeted immunoPET Imaging of Solid Tumors
Phase 2/Phase 3 · 1 location(s) · RenJi Hospital · NCT06851663TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT07377526Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) a
Phase 2 · 1 location(s) · Tianjin Medical University Second Hospital · NCT07179783ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients
NA · 1 location(s) · Deling Li · NCT07177482A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combinat
Phase 3 · 321 location(s) · AstraZeneca · NCT06103864Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study
Phase N/A · 1 location(s) · Peking University Cancer Hospital & Institute · NCT07251868Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer
NA · 1 location(s) · Zhejiang Provincial People's Hospital · NCT07068542A Study of GQ1010 in Subjects With Advanced Solid Tumors
Phase 1/Phase 2 · 5 location(s) · GeneQuantum Healthcare (Suzhou) Co., Ltd. · NCT06464055Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TRO
Phase 2 · 96 location(s) · AstraZeneca · NCT05489211Sacituzumab Govitecan in Recurrent Glioblastoma
Phase 2 · 3 location(s) · The University of Texas Health Science Center at San Antonio · NCT04559230A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Al
Phase 3 · 261 location(s) · Merck Sharp & Dohme LLC · NCT06952504Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06358430A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Phase 1/Phase 2 · 8 location(s) · LigaChem Biosciences, Inc. · NCT05941507Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids
Phase N/A · 1 location(s) · Guangzhou Institute of Respiratory Disease · NCT07610616Target-specific immunoPET Imaging of Breast Cancer
Phase 1/Phase 2 · 1 location(s) · RenJi Hospital · NCT06715826Trop-2 Targeted PET Probes in Advanced TNBC
NA · 1 location(s) · Peking University Cancer Hospital & Institute · NCT07046455DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Phase 2 · 37 location(s) · DualityBio Inc. · NCT06953089Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma
Phase 2 · 1 location(s) · National Taiwan University Hospital · NCT06329869Target-specific immunoPET Imaging of Digestive System Carcinoma
NA · 1 location(s) · RenJi Hospital · NCT06715839The Clinical Study of the Efficacy and Safety of Trop2-ADC Monotherapy or Combination Immunotherapy Strategy in the Trea
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06851299Sacituzumab govitEcan in THYroid Cancers
Phase 2 · 11 location(s) · Grupo Espanol de Tumores Neuroendocrinos · NCT06235216
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.